table_specific

What was the total value of Learningrx's cash and cash equivalents in 2023?

Learningrx Franchise · 2025 FDD

Answer from 2025 FDD Document

planned scope and timing of the audit, significant audit findings, and certain internal control related matters that we identified during the audit.

Springfield, Missouri

January 3, 2024

LearningRx Franchise

Source: Item 23 — RECEIPT (FDD pages 54–209)

What This Means (2025 FDD)

According to Learningrx's 2025 Franchise Disclosure Document, the company's cash and cash equivalents totaled $551,641 in 2023. This figure represents the amount of readily available funds Learningrx had on hand as of September 30, 2023.

Cash and cash equivalents are crucial for covering immediate expenses, managing unforeseen financial challenges, and investing in growth opportunities. A higher value generally indicates better financial stability and flexibility for Learningrx.

For a prospective franchisee, this information provides insight into the financial health of Learningrx. While not a direct indicator of franchisee success, it reflects the franchisor's ability to support its franchisees and manage its own operations effectively. Reviewing trends in cash and cash equivalents over several years can offer a more comprehensive understanding of Learningrx's financial management.

Disclaimer: This information is extracted from the 2025 Franchise Disclosure Document and is provided for research purposes only. It does not constitute legal or financial advice. Consult with a franchise attorney before making any investment decisions.